Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Wojciech Burchardt"'
Autor:
Grzegorz Bielęda, Adam Chicheł, Marek Boehlke, Grzegorz Zwierzchowski, Artur Chyrek, Wojciech Burchardt, Patrycja Stefaniak, Natalia Wiśniewska, Kinga Czereba, Julian Malicki
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 2, Pp 205-214 (2022)
Externí odkaz:
https://doaj.org/article/1ba765c77a9f42c98e1876e5a1c41c5b
Autor:
Wojciech Burchardt, Artur Chyrek, Ewa Burchardt, Grzegorz Bielęda, Maciej Trojanowski, Adam Chicheł
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 11, Iss 6, Pp 534-540 (2019)
Externí odkaz:
https://doaj.org/article/37713fba20de4238b64949528bbc08c5
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 9, p 1382 (2022)
(1) In breast-conserving therapy (BCT), adjuvant radiation, including tumor bed boost, is mandatory. Safely delivered thermal boost (TB) based on radio-sensitizing interstitial microwave hyperthermia (MWHT) preceding standard high-dose-rate (HDR) bra
Externí odkaz:
https://doaj.org/article/a154eaf710e4481d9fbd65a706594987
Autor:
Adam Chicheł, Wojciech Burchardt, Artur J. Chyrek, Grzegorz Bielęda, Grzegorz Zwierzchowski, Patrycja Stefaniak, Julian Malicki
Publikováno v:
Life, Vol 12, Iss 4, p 512 (2022)
(1) Current breast-conserving therapy for breast cancer consists of a combination of many consecutive treatment modalities. The most crucial goal of postoperative treatment is to eradicate potentially relapse-forming residual cancerous cells within t
Externí odkaz:
https://doaj.org/article/a70cc5e959cf4800968c43030a7b6668
Autor:
Ewa Burchardt, Zaneta Warenczak-Florczak, Paulina Cegła, Adam Piotrowski, Zefiryn Cybulski, Wojciech Burchardt, Andrzej Roszak, Witold Cholewiński
Publikováno v:
Diagnostics, Vol 12, Iss 1, p 70 (2021)
This study aims to investigate if vaginal bacteriology obtained prior to treatment influences the 3′-deoxy-3 18F-fluorothymidine (FLT) [18F]FLT and 2-deoxy-2-[18F]fluoro-d-glucose (2-[18F]FDG) [18F]FDG parameters in positron emission tomography (PE
Externí odkaz:
https://doaj.org/article/1cbfdb86e0494dcaa7b14360683d7cb8
Autor:
Ewa Burchardt, Wojciech Burchardt, Paulina Cegła, Anna Kubiak, Andrzej Roszak, Witold Cholewiński
Publikováno v:
Diagnostics, Vol 11, Iss 4, p 714 (2021)
Purpose: This study aims to determine whether semiquantitative parameters obtained from both the primary tumor and metastatic pelvic lymph nodes (PLN) diagnosed in fluoro-18-deoxy-glucose positron emission tomography (FDG-PET-CT) are associated with
Externí odkaz:
https://doaj.org/article/b0e969dd2f254b52941d4a8d7a4d0360
Autor:
Wojciech Burchardt, Artur Jan Chyrek, Adam Chicheł, Magdalena Marciniak, Grzegorz M Biele da, Łukasz Raszewski
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 331-337 (2021)
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy
Purpose The aim of this study was to present a case of complete clinical response of renal clear cell carcinoma cutaneous metastases after high-dose-rate surface brachytherapy (HDR sBT). Material and methods An 81-year-old female diagnosed with stage
Autor:
Ewa, Burchardt, Zaneta, Warenczak-Florczak, Paulina, Cegła, Adam, Piotrowski, Zefiryn, Cybulski, Wojciech, Burchardt, Andrzej, Roszak, Witold, Cholewiński
Publikováno v:
Diagnostics
This study aims to investigate if vaginal bacteriology obtained prior to treatment influences the 3′-deoxy-3 18F-fluorothymidine (FLT) [18F]FLT and 2-deoxy-2-[18F]fluoro-d-glucose (2-[18F]FDG) [18F]FDG parameters in positron emission tomography (PE
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 12, Iss 3, Pp 241-247 (2020)
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy
Purpose Cutaneous B-cell lymphomas (CBCLs) are a rare group of diseases. External beam radiation therapy is recommended to treat CBCLs in all subtypes for locally advanced cases. However, there are no reports on high-dose-rate brachytherapy (HDR-BT)
Autor:
Ewa Burchardt, Wojciech Burchardt
Publikováno v:
Letters in Oncology Science. 16:1-7
Rak prostaty jest drugim co do częstości nowotworem u mężczyzn w Polsce i na świecie. Wskaźniki zachorowalności ciągle rosną, dlatego dane szacunkowe mówią, że w najbliższych latach będzie to najczęściej występujący nowotwór u mę